Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(25%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
5
42%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting2
Active, not recruiting1
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
87.5%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

active_not_recruiting18%
terminated18%
completed758%
recruiting217%
enrolling_by_invitation18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12